The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution

Leukemia. 2015 Jun;29(6):1435-7. doi: 10.1038/leu.2015.7. Epub 2015 Jan 8.

Authors

Affiliations

¹ 1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
² Department of Hematology, Hospital Miguel Servet, Zaragoza, Spain.
³ Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.

PMID: 25567133
DOI: 10.1038/leu.2015.7

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Clonal Evolution
Complementarity Determining Regions / genetics*
Disease Progression
Humans
Immunoglobulin Heavy Chains / genetics*
Multiple Myeloma / diagnosis*
Multiple Myeloma / genetics*
Time Factors

Substances

Complementarity Determining Regions
Immunoglobulin Heavy Chains